Andrew A. Voss
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrew A. Voss has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
Daniel R. Miranda
Department of Biological Sciences, Wright State University, Dayton, USA
5 shared publications- Mark M. Rich
Department of Neuroscience, Cell Biology and Physiology Wright State University Dayton Ohio USA
4 shared publications Robert J. Talmadge
Department of Biological Sciences, California State Polytechnic University, Pomona, USA
4 shared publicationsMark M. Rich
Department of Neuroscience, Cell Biology & Physiology, Wright State University, Dayton, OH, 45435, USA
3 shared publicationsShannon H. Romer
Department of Biological Sciences, Wright State University
3 shared publicationsAbdulrahman Jama
2 shared publications
Latest Publications
- Open Access
- 5 September 2026
- Published by Wiley in The Journal of Physiology
- Vol. 604 (18) , 7799-7818
Efficacy of sodium channel blockers in treating myotonia is independent of action potential sodium current block
The prevailing view holds that the therapeutic benefit of sodium channel blockers arises from use‐dependent inhibition of the transient sodium current (NaT) that is responsible for action potentials. This assumption underlies decades of drug development but has never been directly tested. Our goal was to test this assumption to guide the development of more effective sodium channel blockers. We used a mouse model of myotonia congenita, an ion channelopathy of skeletal muscle, as a system to study mechanism and efficacy of both use‐dependent and closed sodium channel blockers. Intracellular current‐clamp recordings were used to assess excitability during trains of stimuli. The contributions of NaT and a small, non‐inactivating current (Na persistent or NaP) were directly measured with voltage‐clamp recordings. At their effective concentrations none of the sodium channel blockers reduced action potential rate of rise or voltage clamp measures of NaT. In contrast at effective concentrations, all sodium channel blockers studied reduced NaP. A computational model was constructed to test the relative effects of NaT and NaP inhibition on excitability. The model confirmed that NaT block alone could not eliminate myotonia without causing hypoexcitability, whereas partial NaP block was sufficient to abolish pathological discharges while preserving normal firing. These findings redefine the therapeutic mechanism of sodium channel blockade: efficacy does not depend on blocking NaT but correlates with the inhibition of NaP. This shift in perspective reframes strategies for sodium channel drug development and suggests a novel approach to treating myotonia, neuropathic pain, cardiac arrythmia and epilepsy. image Key points: At effective doses that treat hyperexcitability, Na channel blockers have little effect on the sodium current responsible for action potentials. Electrophysiologic recordings and computer simulation suggest that block of a small, persistent, sodium current (NaP) is the mechanism underlying efficacy in treating hyperexcitability. These findings suggest that screens for novel sodium channel blockers focus on block of NaP.
- 5 September 2026
- Published by Wiley in The Journal of Physiology
- Vol. 604 (18) , 7799-7818
Open AccessEfficacy of sodium channel blockers in treating myotonia is independent of action potential sodium current block
The prevailing view holds that the therapeutic benefit of sodium channel blockers arises from use‐dependent inhibition of the transient sodium current (NaT) that is responsible for action potentials. This assumption underlies decades of drug development but has never been directly tested. Our goal was to test this assumption to guide the development of more effective sodium channel blockers. We used a mouse model of myotonia congenita, an ion channelopathy of skeletal muscle, as a system to study mechanism and efficacy of both use‐dependent and closed sodium channel blockers. Intracellular current‐clamp recordings were used to assess excitability during trains of stimuli. The contributions of NaT and a small, non‐inactivating current (Na persistent or NaP) were directly measured with voltage‐clamp recordings. At their effective concentrations none of the sodium channel blockers reduced action potential rate of rise or voltage clamp measures of NaT. In contrast at effective concentrations, all sodium channel blockers studied reduced NaP. A computational model was constructed to test the relative effects of NaT and NaP inhibition on excitability. The model confirmed that NaT block alone could not eliminate myotonia without causing hypoexcitability, whereas partial NaP block was sufficient to abolish pathological discharges while preserving normal firing. These findings redefine the therapeutic mechanism of sodium channel blockade: efficacy does not depend on blocking NaT but correlates with the inhibition of NaP. This shift in perspective reframes strategies for sodium channel drug development and suggests a novel approach to treating myotonia, neuropathic pain, cardiac arrythmia and epilepsy. image Key points: At effective doses that treat hyperexcitability, Na channel blockers have little effect on the sodium current responsible for action potentials. Electrophysiologic recordings and computer simulation suggest that block of a small, persistent, sodium current (NaP) is the mechanism underlying efficacy in treating hyperexcitability. These findings suggest that screens for novel sodium channel blockers focus on block of NaP.
- Open Access
- 19 February 2026
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 478 (2) , 24
Integrated effects of altered action potentials and calcium release on skeletal muscle force generation in transgenic Huntington’s disease mice
Huntington’s disease (HD) is a movement disorder commonly recognized as being neurodegenerative. An increasing number of studies also show primary HD dysfunction in multiple tissues, consistent with the widespread expression of the mutated huntingtin gene. Studies of HD skeletal muscle have revealed membrane hyperexcitability and prolonged action potentials due to Cl – and K + channel dysfunction as well as decreased Ca 2+ release from the sarcoplasmic reticulum (SR) due to ryanodine receptor dysfunction. However, neither mechanism alone explains HD skeletal muscle function. To address this, we simultaneously recorded action potentials and SR Ca 2+ release in model HD muscle and quantitatively linked the concerted mechanism to force generation. We discovered that the reduced SR Ca 2+ release does not cause weakness in model HD muscle as expected because of the prolonged SR Ca 2+ release (due to wider action potentials) and altered expression of Ca 2+ -binding proteins. The resulting integrated mechanism helps explains the surprisingly normal specific twitch force in model HD muscle and reveals a precarious balance that we show begins to disintegrate under very mild repetitive stimulation. The interplay of pathways also explains the resistance to myotonia in model HD muscle despite the substantial reduction in Cl − current. By examining a concerted multi-molecular mechanism, we are able to understand tissue-level function in model HD muscle. This detailed study of twitch responses lays the foundation to examine the more complex integration of pathways during repetitive activity in HD muscle as well as in other normal and disease states that would benefit from the multi-molecular approach.
- 19 February 2026
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 478 (2) , 24
Open AccessIntegrated effects of altered action potentials and calcium release on skeletal muscle force generation in transgenic Huntington’s disease mice
Huntington’s disease (HD) is a movement disorder commonly recognized as being neurodegenerative. An increasing number of studies also show primary HD dysfunction in multiple tissues, consistent with the widespread expression of the mutated huntingtin gene. Studies of HD skeletal muscle have revealed membrane hyperexcitability and prolonged action potentials due to Cl – and K + channel dysfunction as well as decreased Ca 2+ release from the sarcoplasmic reticulum (SR) due to ryanodine receptor dysfunction. However, neither mechanism alone explains HD skeletal muscle function. To address this, we simultaneously recorded action potentials and SR Ca 2+ release in model HD muscle and quantitatively linked the concerted mechanism to force generation. We discovered that the reduced SR Ca 2+ release does not cause weakness in model HD muscle as expected because of the prolonged SR Ca 2+ release (due to wider action potentials) and altered expression of Ca 2+ -binding proteins. The resulting integrated mechanism helps explains the surprisingly normal specific twitch force in model HD muscle and reveals a precarious balance that we show begins to disintegrate under very mild repetitive stimulation. The interplay of pathways also explains the resistance to myotonia in model HD muscle despite the substantial reduction in Cl − current. By examining a concerted multi-molecular mechanism, we are able to understand tissue-level function in model HD muscle. This detailed study of twitch responses lays the foundation to examine the more complex integration of pathways during repetitive activity in HD muscle as well as in other normal and disease states that would benefit from the multi-molecular approach.
- Open Access
- 5 May 2023
- Published by Wiley in Physiological Reports
- Vol. 11 (9) , e15675
Voltage sensor current, SR Ca2+ release, and Ca2+ channel current during trains of action potential‐like depolarizations of skeletal muscle fibers
In skeletal muscle, CaV1.1 serves as the voltage sensor for both excitation‐contraction coupling (ECC) and L‐type Ca2+ channel activation. We have recently adapted the technique of action potential (AP) voltage clamp (APVC) to monitor the current generated by the movement of intramembrane voltage sensors (IQ) during single imposed transverse tubular AP‐like depolarization waveforms (IQAP). We now extend this procedure to monitoring IQAP, and Ca2+ currents during trains of tubular AP‐like waveforms in adult murine skeletal muscle fibers, and compare them with the trajectories of APs and AP‐induced Ca2+ release measured in other fibers using field stimulation and optical probes. The AP waveform remains relatively constant during brief trains (QAP amplitude or kinetics, consistent with previous findings in isolated muscle fibers where negligible charge immobilization occurred during 100 ms step depolarizations. Using field stimulation, Ca2+ release did exhibit a considerable decline from pulse to pulse during the train, also consistent with previous findings, indicating that the decline of Ca2+ release during a short train of APs is not correlated to modification of charge movement. Ca2+ currents during single or 10 Hz trains of AP‐like depolarizations were hardly detectable, were minimal during 50 Hz trains, and became more evident during 100 Hz trains in some fibers. Our results verify predictions on the behavior of the ECC machinery in response to AP‐like depolarizations and provide a direct demonstration that Ca2+ currents elicited by single AP‐like waveforms are negligible, but can become more prominent in some fibers during short high‐frequency train stimulation that elicits maximal isometric force.
- 5 May 2023
- Published by Wiley in Physiological Reports
- Vol. 11 (9) , e15675
Open AccessVoltage sensor current, SR Ca2+ release, and Ca2+ channel current during trains of action potential‐like depolarizations of skeletal muscle fibers
In skeletal muscle, CaV1.1 serves as the voltage sensor for both excitation‐contraction coupling (ECC) and L‐type Ca2+ channel activation. We have recently adapted the technique of action potential (AP) voltage clamp (APVC) to monitor the current generated by the movement of intramembrane voltage sensors (IQ) during single imposed transverse tubular AP‐like depolarization waveforms (IQAP). We now extend this procedure to monitoring IQAP, and Ca2+ currents during trains of tubular AP‐like waveforms in adult murine skeletal muscle fibers, and compare them with the trajectories of APs and AP‐induced Ca2+ release measured in other fibers using field stimulation and optical probes. The AP waveform remains relatively constant during brief trains (QAP amplitude or kinetics, consistent with previous findings in isolated muscle fibers where negligible charge immobilization occurred during 100 ms step depolarizations. Using field stimulation, Ca2+ release did exhibit a considerable decline from pulse to pulse during the train, also consistent with previous findings, indicating that the decline of Ca2+ release during a short train of APs is not correlated to modification of charge movement. Ca2+ currents during single or 10 Hz trains of AP‐like depolarizations were hardly detectable, were minimal during 50 Hz trains, and became more evident during 100 Hz trains in some fibers. Our results verify predictions on the behavior of the ECC machinery in response to AP‐like depolarizations and provide a direct demonstration that Ca2+ currents elicited by single AP‐like waveforms are negligible, but can become more prominent in some fibers during short high‐frequency train stimulation that elicits maximal isometric force.
- Open Access
- 13 April 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , S718
Abstract 1467: The Role of Lipin1 in Skeletal Muscle of mdx Mice
- 13 April 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , S718
Open AccessAbstract 1467: The Role of Lipin1 in Skeletal Muscle of mdx Mice
- Open Access
- 5 December 2021
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 28, 101182
Acetylcholine receptor subunit expression in Huntington's disease mouse muscle
- 5 December 2021
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 28, 101182
Open AccessAcetylcholine receptor subunit expression in Huntington's disease mouse muscle
- 1 September 2021
- Published by Elsevier in Cell Calcium
- Vol. 98, 102439
Into the spotlight: RGK proteins in skeletal muscle
- 1 September 2021
- Published by Elsevier in Cell Calcium
- Vol. 98, 102439
Into the spotlight: RGK proteins in skeletal muscle
- Open Access
- 8 March 2021
- Published by Rockefeller University Press in Journal of General Physiology
- Vol. 153 (4)
A mouse model of Huntington’s disease shows altered ultrastructure of transverse tubules in skeletal muscle fibers
Huntington’s disease (HD) is a fatal and progressive condition with severe debilitating motor defects and muscle weakness. Although classically recognized as a neurodegenerative disorder, there is increasing evidence of cell autonomous toxicity in skeletal muscle. We recently demonstrated that skeletal muscle fibers from the R6/2 model mouse of HD have a decrease in specific membrane capacitance, suggesting a loss of transverse tubule (t-tubule) membrane in R6/2 muscle. A previous report also indicated that Cav1.1 current was reduced in R6/2 skeletal muscle, suggesting defects in excitation–contraction (EC) coupling. Thus, we hypothesized that a loss and/or disruption of the skeletal muscle t-tubule system contributes to changes in EC coupling in R6/2 skeletal muscle. We used live-cell imaging with multiphoton confocal microscopy and transmission electron microscopy to assess the t-tubule architecture in late-stage R6/2 muscle and found no significant differences in the t-tubule system density, regularity, or integrity. However, electron microscopy images revealed that the cross-sectional area of t-tubules at the triad were 25% smaller in R6/2 compared with age-matched control skeletal muscle. Computer simulation revealed that the resulting decrease in the R6/2 t-tubule luminal conductance contributed to, but did not fully explain, the reduced R6/2 membrane capacitance. Analyses of bridging integrator-1 (Bin1), which plays a primary role in t-tubule formation, revealed decreased Bin1 protein levels and aberrant splicing of Bin1 mRNA in R6/2 muscle. Additionally, the distance between the t-tubule and sarcoplasmic reticulum was wider in R6/2 compared with control muscle, which was associated with a decrease in junctophilin 1 and 2 mRNA levels. Altogether, these findings can help explain dysregulated EC coupling and motor impairment in Huntington’s disease.
- 8 March 2021
- Published by Rockefeller University Press in Journal of General Physiology
- Vol. 153 (4)
Open AccessA mouse model of Huntington’s disease shows altered ultrastructure of transverse tubules in skeletal muscle fibers
Huntington’s disease (HD) is a fatal and progressive condition with severe debilitating motor defects and muscle weakness. Although classically recognized as a neurodegenerative disorder, there is increasing evidence of cell autonomous toxicity in skeletal muscle. We recently demonstrated that skeletal muscle fibers from the R6/2 model mouse of HD have a decrease in specific membrane capacitance, suggesting a loss of transverse tubule (t-tubule) membrane in R6/2 muscle. A previous report also indicated that Cav1.1 current was reduced in R6/2 skeletal muscle, suggesting defects in excitation–contraction (EC) coupling. Thus, we hypothesized that a loss and/or disruption of the skeletal muscle t-tubule system contributes to changes in EC coupling in R6/2 skeletal muscle. We used live-cell imaging with multiphoton confocal microscopy and transmission electron microscopy to assess the t-tubule architecture in late-stage R6/2 muscle and found no significant differences in the t-tubule system density, regularity, or integrity. However, electron microscopy images revealed that the cross-sectional area of t-tubules at the triad were 25% smaller in R6/2 compared with age-matched control skeletal muscle. Computer simulation revealed that the resulting decrease in the R6/2 t-tubule luminal conductance contributed to, but did not fully explain, the reduced R6/2 membrane capacitance. Analyses of bridging integrator-1 (Bin1), which plays a primary role in t-tubule formation, revealed decreased Bin1 protein levels and aberrant splicing of Bin1 mRNA in R6/2 muscle. Additionally, the distance between the t-tubule and sarcoplasmic reticulum was wider in R6/2 compared with control muscle, which was associated with a decrease in junctophilin 1 and 2 mRNA levels. Altogether, these findings can help explain dysregulated EC coupling and motor impairment in Huntington’s disease.
- 20 May 2020
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 319 (1) , C218-C232
Mechanisms of altered skeletal muscle action potentials in the R6/2 mouse model of Huntington’s disease
Huntington’s disease (HD) patients suffer from progressive and debilitating motor dysfunction for which only palliative treatment is currently available. Previously, we discovered reduced skeletal muscle Cl− channel (ClC-1) and inwardly rectifying K+ channel (Kir) currents in R6/2 HD transgenic mice. To further investigate the role of ClC-1 and Kir currents in HD skeletal muscle pathology, we measured the effect of reduced ClC-1 and Kir currents on action potential (AP) repetitive firing in R6/2 mice using a two-electrode current clamp. We found that R6/2 APs had a significantly lower peak amplitude, depolarized maximum repolarization, and prolonged decay time compared with wild type (WT). Of these differences, only the maximum repolarization was accounted for by the reduction in ClC-1 and Kir currents, indicating the presence of additional ion channel defects. We found that both KV1.5 and KV3.4 mRNA levels were significantly reduced in R6/2 skeletal muscle compared with WT, which explains the prolonged decay time of R6/2 APs. Overall, we found that APs in WT and R6/2 muscle significantly and progressively change during activity to maintain peak amplitude despite buildup of Na+ channel inactivation. Even with this resilience, the persistently reduced peak amplitude of R6/2 APs is expected to result in earlier fatigue and may help explain the motor impersistence experienced by HD patients. This work lays the foundation to link electrical changes to force generation defects in R6/2 HD mice and to examine the regulatory events controlling APs in WT muscle.
- 20 May 2020
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 319 (1) , C218-C232
Mechanisms of altered skeletal muscle action potentials in the R6/2 mouse model of Huntington’s disease
Huntington’s disease (HD) patients suffer from progressive and debilitating motor dysfunction for which only palliative treatment is currently available. Previously, we discovered reduced skeletal muscle Cl− channel (ClC-1) and inwardly rectifying K+ channel (Kir) currents in R6/2 HD transgenic mice. To further investigate the role of ClC-1 and Kir currents in HD skeletal muscle pathology, we measured the effect of reduced ClC-1 and Kir currents on action potential (AP) repetitive firing in R6/2 mice using a two-electrode current clamp. We found that R6/2 APs had a significantly lower peak amplitude, depolarized maximum repolarization, and prolonged decay time compared with wild type (WT). Of these differences, only the maximum repolarization was accounted for by the reduction in ClC-1 and Kir currents, indicating the presence of additional ion channel defects. We found that both KV1.5 and KV3.4 mRNA levels were significantly reduced in R6/2 skeletal muscle compared with WT, which explains the prolonged decay time of R6/2 APs. Overall, we found that APs in WT and R6/2 muscle significantly and progressively change during activity to maintain peak amplitude despite buildup of Na+ channel inactivation. Even with this resilience, the persistently reduced peak amplitude of R6/2 APs is expected to result in earlier fatigue and may help explain the motor impersistence experienced by HD patients. This work lays the foundation to link electrical changes to force generation defects in R6/2 HD mice and to examine the regulatory events controlling APs in WT muscle.
- Open Access
- 3 April 2020
- Published by Rockefeller University Press in Journal of General Physiology
- Vol. 152 (5)
Depressed neuromuscular transmission causes weakness in mice lacking BK potassium channels
Mice lacking functional large-conductance voltage- and Ca2+-activated K+ channels (BK channels) are viable but have motor deficits including ataxia and weakness. The cause of weakness is unknown. In this study, we discovered, in vivo, that skeletal muscle in mice lacking BK channels (BK−/−) was weak in response to nerve stimulation but not to direct muscle stimulation, suggesting a failure of neuromuscular transmission. Voltage-clamp studies of the BK−/− neuromuscular junction (NMJ) revealed a reduction in evoked endplate current amplitude and the frequency of spontaneous vesicle release compared with WT littermates. Responses to 50-Hz stimulation indicated a reduced probability of vesicle release in BK−/− mice, suggestive of lower presynaptic Ca2+ entry. Pharmacological block of BK channels in WT NMJs did not affect NMJ function, surprisingly suggesting that the reduced vesicle release in BK−/− NMJs was not due to loss of BK channel–mediated K+ current. Possible explanations for our data include an effect of BK channels on development of the NMJ, a role for BK channels in regulating presynaptic Ca2+ current or the effectiveness of Ca2+ in triggering release. Consistent with reduced Ca2+ entry or effectiveness of Ca2+ in triggering release, use of 3,4-diaminopyridine to widen action potentials normalized evoked release in BK−/− mice to WT levels. Intraperitoneal application of 3,4-diaminopyridine fully restored in vivo nerve-stimulated muscle force in BK−/− mice. Our work demonstrates that mice lacking BK channels have weakness due to a defect in vesicle release at the NMJ.
- 3 April 2020
- Published by Rockefeller University Press in Journal of General Physiology
- Vol. 152 (5)
Open AccessDepressed neuromuscular transmission causes weakness in mice lacking BK potassium channels
Mice lacking functional large-conductance voltage- and Ca2+-activated K+ channels (BK channels) are viable but have motor deficits including ataxia and weakness. The cause of weakness is unknown. In this study, we discovered, in vivo, that skeletal muscle in mice lacking BK channels (BK−/−) was weak in response to nerve stimulation but not to direct muscle stimulation, suggesting a failure of neuromuscular transmission. Voltage-clamp studies of the BK−/− neuromuscular junction (NMJ) revealed a reduction in evoked endplate current amplitude and the frequency of spontaneous vesicle release compared with WT littermates. Responses to 50-Hz stimulation indicated a reduced probability of vesicle release in BK−/− mice, suggestive of lower presynaptic Ca2+ entry. Pharmacological block of BK channels in WT NMJs did not affect NMJ function, surprisingly suggesting that the reduced vesicle release in BK−/− NMJs was not due to loss of BK channel–mediated K+ current. Possible explanations for our data include an effect of BK channels on development of the NMJ, a role for BK channels in regulating presynaptic Ca2+ current or the effectiveness of Ca2+ in triggering release. Consistent with reduced Ca2+ entry or effectiveness of Ca2+ in triggering release, use of 3,4-diaminopyridine to widen action potentials normalized evoked release in BK−/− mice to WT levels. Intraperitoneal application of 3,4-diaminopyridine fully restored in vivo nerve-stimulated muscle force in BK−/− mice. Our work demonstrates that mice lacking BK channels have weakness due to a defect in vesicle release at the NMJ.
- 5 May 2018
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 135,p. e57482
Levator Auris Longus Preparation for Examination of Mammalian Neuromuscular Transmission Under Voltage Clamp Conditions
This protocol describes a technique to record synaptic transmission from the neuromuscular junction under current-clamp and voltage-clamp conditions. An ex vivo preparation of the levator auris longus (LAL) is used because it is a thin muscle that provides easy visualization of the neuromuscular junction for microelectrode impalement at the motor endplate. This method allows for the recording of spontaneous miniature endplate potentials and currents (mEPPs and mEPCs), nerve-evoked endplate potentials and currents (EPPs and EPCs), as well as the membrane properties of the motor endplate. Results obtained from this method include the quantal content (QC), number of vesicle release sites (n), probability of vesicle release (prel), synaptic facilitation and depression, as well as the muscle membrane time constant (τm) and input resistance. Application of this technique to mouse models of human disease can highlight key pathologies in disease states and help identify novel treatment strategies. By fully voltage-clamping a single synapse, this method provides one of the most detailed analyses of synaptic transmission currently available.
- 5 May 2018
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 135,p. e57482
Levator Auris Longus Preparation for Examination of Mammalian Neuromuscular Transmission Under Voltage Clamp Conditions
This protocol describes a technique to record synaptic transmission from the neuromuscular junction under current-clamp and voltage-clamp conditions. An ex vivo preparation of the levator auris longus (LAL) is used because it is a thin muscle that provides easy visualization of the neuromuscular junction for microelectrode impalement at the motor endplate. This method allows for the recording of spontaneous miniature endplate potentials and currents (mEPPs and mEPCs), nerve-evoked endplate potentials and currents (EPPs and EPCs), as well as the membrane properties of the motor endplate. Results obtained from this method include the quantal content (QC), number of vesicle release sites (n), probability of vesicle release (prel), synaptic facilitation and depression, as well as the muscle membrane time constant (τm) and input resistance. Application of this technique to mouse models of human disease can highlight key pathologies in disease states and help identify novel treatment strategies. By fully voltage-clamping a single synapse, this method provides one of the most detailed analyses of synaptic transmission currently available.